JP2023540960A5 - - Google Patents
Info
- Publication number
- JP2023540960A5 JP2023540960A5 JP2023514770A JP2023514770A JP2023540960A5 JP 2023540960 A5 JP2023540960 A5 JP 2023540960A5 JP 2023514770 A JP2023514770 A JP 2023514770A JP 2023514770 A JP2023514770 A JP 2023514770A JP 2023540960 A5 JP2023540960 A5 JP 2023540960A5
- Authority
- JP
- Japan
- Prior art keywords
- aav
- protein
- aavlp
- amino acid
- amino acids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20195554 | 2020-09-10 | ||
| EP20195554.9 | 2020-09-10 | ||
| PCT/EP2021/074987 WO2022053642A1 (en) | 2020-09-10 | 2021-09-10 | Engineered aav vectors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023540960A JP2023540960A (ja) | 2023-09-27 |
| JP2023540960A5 true JP2023540960A5 (enExample) | 2024-09-19 |
Family
ID=72744535
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023514770A Pending JP2023540960A (ja) | 2020-09-10 | 2021-09-10 | 操作されたａａｖベクター |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230365942A1 (enExample) |
| EP (1) | EP4211232A1 (enExample) |
| JP (1) | JP2023540960A (enExample) |
| CN (1) | CN116323641A (enExample) |
| AU (1) | AU2021339003A1 (enExample) |
| CA (1) | CA3188763A1 (enExample) |
| WO (1) | WO2022053642A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4353737A1 (en) * | 2022-10-10 | 2024-04-17 | Universitätsklinikum Hamburg-Eppendorf | Fusion proteins comprising a cell surface marker specific vhh |
| CN119552829A (zh) * | 2023-09-01 | 2025-03-04 | 北京昌平实验室 | 靶向性基因编辑酶工程化的腺相关病毒及其药物组合物 |
| WO2025059487A2 (en) | 2023-09-15 | 2025-03-20 | Othair Prothena Limited | Cell penetrating agents and uses thereof |
| EP4777522A2 (en) | 2023-09-15 | 2026-07-22 | Prothena Platform Technologies Limited | Methods, compositions, and kits including cell-penetrating agents |
| WO2026052740A1 (en) * | 2024-09-04 | 2026-03-12 | Rockberg Johan Sven Erik | Modular platform for gene therapy |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5478745A (en) | 1992-12-04 | 1995-12-26 | University Of Pittsburgh | Recombinant viral vector system |
| WO1998045401A2 (de) | 1997-04-08 | 1998-10-15 | Tuchenhagen Gmbh | Verfahren und anordnung zur beschleunigten gärung in zylindrokonischen gärtanks bei der herstellung von bier |
| CN103589692B (zh) | 2001-11-13 | 2018-07-24 | 宾夕法尼亚大学托管会 | 检测和/或鉴定腺伴随病毒(aav)序列以及分离所鉴定的新型序列的方法 |
| EP2012122A1 (en) * | 2007-07-06 | 2009-01-07 | Medigene AG | Mutated parvovirus structural proteins as vaccines |
| AR082925A1 (es) | 2010-09-08 | 2013-01-16 | Medigene Ag | Proteinas estructurales mutadas por parvovirus con epitopo de celulas b de proteccion cruzada, producto y metodos relacionados |
| US10370432B2 (en) | 2014-10-03 | 2019-08-06 | University Of Massachusetts | Heterologous targeting peptide grafted AAVS |
| EP3527223A1 (en) | 2018-02-16 | 2019-08-21 | 2A Pharma AB | Mutated parvovirus structural protein |
| EP3564263A1 (en) * | 2018-05-03 | 2019-11-06 | Universitätsklinikum Hamburg-Eppendorf | Fusion proteins comprising a cell surface marker specific vhh |
| CN111375055B (zh) * | 2020-02-20 | 2021-09-03 | 陈宛莎 | 一种2019-nCoV亚单位疫苗组合物及其免疫方法 |
| CN111411118A (zh) * | 2020-03-31 | 2020-07-14 | 鲲羽生物科技(江门)有限公司 | 抗病原高免卵黄抗体及基于aav载体疫苗制备的方法和制剂 |
| CN111560354B (zh) * | 2020-05-22 | 2022-07-19 | 中国人民解放军总医院第五医学中心 | 重组新型冠状病毒及其制备方法和应用 |
-
2021
- 2021-09-10 AU AU2021339003A patent/AU2021339003A1/en active Pending
- 2021-09-10 US US18/044,628 patent/US20230365942A1/en active Pending
- 2021-09-10 WO PCT/EP2021/074987 patent/WO2022053642A1/en not_active Ceased
- 2021-09-10 CA CA3188763A patent/CA3188763A1/en active Pending
- 2021-09-10 EP EP21777282.1A patent/EP4211232A1/en active Pending
- 2021-09-10 JP JP2023514770A patent/JP2023540960A/ja active Pending
- 2021-09-10 CN CN202180055061.6A patent/CN116323641A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12534717B2 (en) | AAV capsid proteins for nucleic acid transfer | |
| US20220184227A1 (en) | Mutated adeno-associated virus capsid proteins, aav particle comprising the same and liver directed aav vector gene therapy | |
| JP5136766B2 (ja) | キメラベクター | |
| US7220577B2 (en) | Modified AAV | |
| US20070172460A1 (en) | Random peptide library displayed on aav vectors | |
| JP2022502046A5 (enExample) | ||
| JP2021516044A (ja) | 抗体回避ウイルスベクターのための方法および組成物 | |
| JP7524166B2 (ja) | 脳に指向性を有するａａｖ変異体 | |
| JP7737385B2 (ja) | 遺伝子療法のためのａａｖ２をベースとするウイルスベクター粒子 | |
| WO2013170078A1 (en) | Adeno associated virus plasmids and vectors | |
| JP2011067212A (ja) | ハイブリッドウイルス粒子とその製造方法 | |
| JP2024050766A (ja) | 改変ウイルスカプシド | |
| JPH11500007A (ja) | 組換えアデノウイルスゲノムの製造方法 | |
| KR20250102136A (ko) | 중추 신경계에서의 유전자 발현을 위한 핵산 조절 요소 및 사용 방법 | |
| US20230365942A1 (en) | Engineered aav vectors | |
| JP2024515626A (ja) | 血液脳関門を横断し低減された液性応答を惹起する合理的ポリプロイドａａｖビリオン | |
| CN118345117A (zh) | 重组腺相关病毒大基因包装表达载体的构建生产和用途 | |
| EP4410988A1 (en) | An aav2-vector variant for targeted transfer of genes | |
| CN118324853B (zh) | 腺相关病毒突变体及其应用 | |
| US12509490B2 (en) | AAV capsids for targeting nervous system and uses thereof | |
| RU2809389C2 (ru) | Мутант aav, обладающий способностью нацеливаться на головной мозг | |
| WO2025057943A1 (ja) | 内耳に感染性を有するａａｖ変異体 | |
| CN120981475A (zh) | 变体aav9衣壳蛋白及其用途 | |
| HK40069854A (en) | Aav mutant having brain-targeting property | |
| HK40048077B (en) | Synthetic liver-tropic adeno-associated virus capsids and uses thereof |